55 related articles for article (PubMed ID: 2128822)
1. [Lessons of the socioeconomic structure of a cohort of 50 drug addicts infected with HIV and followed up over a year].
Pène P; Gallais H; Chaudet H; Clouet MN
Bull Acad Natl Med; 1990 Nov; 174(8):1141-8; discussion 1149. PubMed ID: 2128822
[TBL] [Abstract][Full Text] [Related]
2. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
[TBL] [Abstract][Full Text] [Related]
3. [Aspects of human immunodeficiency virus infection in Languedoc-Roussillon].
Bertrand A; Reynes J
Bull Acad Natl Med; 1988 Oct; 172(7):919-25. PubMed ID: 3072985
[TBL] [Abstract][Full Text] [Related]
4. Income and employment of people living with combined HIV/AIDS, chronic mental illness, and substance abuse disorders.
Conover CJ; Arno P; Weaver M; Ang A; Ettner SL
J Ment Health Policy Econ; 2006 Jun; 9(2):71-86. PubMed ID: 17007485
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of HIV infection in the drug addicts of Bangladesh: drug habit, sexual practice and lifestyle.
Islam SK; Hossain KJ; Kamal M; Ahsan M
Int J STD AIDS; 2003 Nov; 14(11):762-4. PubMed ID: 14624740
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic differences in the impact of HIV infection on workforce participation in France in the era of highly active antiretroviral therapy.
Dray-Spira R; Gueguen A; Ravaud JF; Lert F
Am J Public Health; 2007 Mar; 97(3):552-8. PubMed ID: 17267720
[TBL] [Abstract][Full Text] [Related]
7. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998.
Lebouché B; Yazdanpanah Y; Gérard Y; Sissoko D; Ajana F; Alcaraz I; Boitte P; Cadoré B; Mouton Y
HIV Med; 2006 Apr; 7(3):140-5. PubMed ID: 16494627
[TBL] [Abstract][Full Text] [Related]
8. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
Fhima A; Henrion R; Lowenstein W; Charpak Y
Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
[TBL] [Abstract][Full Text] [Related]
9. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
10. Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART.
Stoll M; Claes C; Schulte E; Graf von der Schulenburg JM; Schmidt RE
Eur J Med Res; 2002 Nov; 7(11):463-71. PubMed ID: 12568973
[TBL] [Abstract][Full Text] [Related]
11. [Causes of death in HIV-infected French drug users, 1995-2000].
Lewden C; Bonnet F; Bevilacqua S; Heripret L; May T; Morlat P; Jougla E; Dabis F; Chêne G; Salmon D; ;
Ann Med Interne (Paris); 2002 Nov; 153(7 Suppl):2S4-10. PubMed ID: 12518077
[TBL] [Abstract][Full Text] [Related]
12. Economic consequences of HIV/AIDS in India.
Pandav CS; Anand K; Shamanna BR; Chowdhury S; Nath LM
Natl Med J India; 1997; 10(1):27-30. PubMed ID: 9069706
[TBL] [Abstract][Full Text] [Related]
13. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
[TBL] [Abstract][Full Text] [Related]
14. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
Duburcq A; Charpak Y; Blin P; Madec L
Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
[TBL] [Abstract][Full Text] [Related]
15. [HIV infection declines among intravenous drug addicts in Barcelona: 1987-1993].
Muga R; Egea JM; Tor J; Rodríguez R; Roca J; Giménez G; Foz M
Med Clin (Barc); 1994 Nov; 103(15):567-70. PubMed ID: 7990521
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus infection in a cohort of intravenous drug users in New York City. Demographic, behavioral, and clinical features.
Brown LS; Chu A; Nemoto T; Ajuluchukwu D; Primm BJ
N Y State J Med; 1989 Sep; 89(9):506-10. PubMed ID: 2797531
[TBL] [Abstract][Full Text] [Related]
17. [The socioeconomic consequences of HIV infection in women and children].
Henrion R; Mandelbrot L
Bull Acad Natl Med; 1990 Nov; 174(8):1151-9. PubMed ID: 2128823
[TBL] [Abstract][Full Text] [Related]
18. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
Goeb JL; Coste J; Bigot T; Ferrand I
Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
[TBL] [Abstract][Full Text] [Related]
19. [Rates of human immunodeficiency virus (HIV) infection in intravenous drug addicts from the Barcelona area, according to sex and age of drug consumption onset].
Egea JM; Tor J; Muga R; Roca J; Rodríguez R; Navío M; Rey-Joly C
Med Clin (Barc); 1996 Jan; 106(3):87-90. PubMed ID: 8948942
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of human immunodeficiency virus infection in drug addicts assisted from 1991 to 1996 at a detoxification center in Castilla y Leon].
Alba A; Terán A; Cuende JI; Sánchez S; González C
Enferm Infecc Microbiol Clin; 1998 Apr; 16(4):169-74. PubMed ID: 9646560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
